Invention Grant
- Patent Title: Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof
-
Application No.: US15546887Application Date: 2016-01-29
-
Publication No.: US10336748B2Publication Date: 2019-07-02
- Inventor: Mark Edward Schnute , Andrew Christopher Flick , Peter Jones , Neelu Kaila , Scot Richard Mente , John David Trzupek , Michael L. Vazquez , Goran Mattias Wennerstal , Li Xing , Edouard Zamaratski , Liying Zhang , Rayomand J. Unwalla
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent James T. Wasicak
- International Application: PCT/IB2016/050473 WO 20160129
- International Announcement: WO2016/120849 WO 20160804
- Main IPC: C07D471/04
- IPC: C07D471/04
Abstract:
The present invention provides methoxy-substituted pyrrolopyridines, pharmaceutical compositions thereof, methods of modulating RORγ activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such pyrrolopyridines and pharmaceutical compositions thereof.
Public/Granted literature
- US20180002330A1 Methyoxy-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof Public/Granted day:2018-01-04
Information query
